Scientists from Novosibirsk are currently creating a pleasant and harmless vaccine – an edible one. So far, they managed to incorporate the protein gene – HIV antigen in tomatoes. The research is supported by International Science and Technology Center (ISTC).
All patients would be overjoyed to get edible vaccines, contained in vegetables and fruit. Imagine, a patient eats a vaccine and this way gets protected from a dangerous infection. However, this is not a fantasy, the fact being confirmed by the research carried out by scientists all over the world. They are working hard to create an edible vaccine against HIV - a lethal virus. Russian researchers from ‘Vector’ State Scientific Center for Virology and Biotechnology jointly with the specialists from the Institute for Biological Chemistry and Fundamental Medicine in Novosibirsk, Siberian Institute for Plants Physiology and Biochemistry, Irkutsk, and the scientists from the Department for Agricultural Research, Maryland, USA are also working at this challenge. They are not at the stage of creating the vaccine yet, but the biologists have managed to incorporate the right gene into tomato plants and have proved that the protein required for the vaccine is not only contained in tomato leaves, but in tomato fruit. And this is a considerable achievement.
By the way, tomatoes have not been chosen by chance. The matter is that transgenic plants, which contain protein- HIV antigen, have already been cultivated, but these plants are either not edible, like tobacco, or must be thermally processed, like potatoes, and this way they practically lose their healing powers. To this end tomato serves ideally. The good thing is that this vegetable grows pretty well in Russia, compared to bananas, already used by Western scientists to produce vaccines.
Sergey Komarov | alfa
Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH
Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences